Damon Runyon Researchers

Meet Our Scientists
Raymond E. Moellering, PhD

Dr. Moellering is interested in understanding the link between alteration of metabolic pathways and corresponding protein modifications that occur in cancer cells. In addition, he is investigating whether cancer cells use small molecule signaling, known as quorum-sensing, to communicate and thus control tumor initiation, growth and metastasis. His goal is to provide insights into many aspects of tumor progression and to potentially identify new opportunities for therapeutic intervention. 

Project title: "Characterization of novel pathogenic pathways in cancer: do tumor cells use quorum-sensing molecules to support malignancy?"
Institution: The University of Chicago
Award Program: Dale Frey Scientist
Cancer Type: All Cancers
Research Area: Chemical Biology